News

home News

[230810 Àú³Î¹ßÇ¥] De novo design of protein structure and function with RFdiffusion

Á¤¼±¿ì ¦¢ 2023-08-10

HIT

28336

Published 11 July 2023

De novo design of protein structure and function with RFdiffusion

Nature (2023)

Abstract

There has been considerable recent progress in designing new proteins using deep learning methods. Despite this progress, a general deep learning framework for protein design that enables solution of a wide range of design challenges, including de novo binder design and design of higher order symmetric architectures, has yet to be described. Diffusion models have had considerable success in image and language generative modeling but limited success when applied to protein modeling, likely due to the complexity of protein backbone geometry and sequence-structure relationships. Here we show that by fine tuning the RoseTTAFold structure prediction network on protein structure denoising tasks, we obtain a generative model of protein backbones that achieves outstanding performance on unconditional and topology-constrained protein monomer design, protein binder design, symmetric oligomer design, enzyme active site scaffolding, and symmetric motif scaffolding for therapeutic and metal-binding protein design. We demonstrate the power and generality of the method, called RoseTTAFold Diffusion (RFdiffusion), by experimentally characterizing the structures and functions of hundreds of designed symmetric assemblies, metal binding proteins and protein binders. The accuracy of RFdiffusion is confirmed by the cryo-EM structure of a designed binder in complex with Influenza hemagglutinin which is nearly identical to the design model. In a manner analogous to networks which produce images from user-specified inputs, RFdiffusion enables the design of diverse functional proteins from simple molecular specifications.

https://www.nature.com/articles/s41586-023-06415-8




Prev [2023.08.10 Àú³Î¹ßÇ¥] ¥â2-Microglobulin coaggregates with A¥â and contributes to...
Next [230818 Àú³Î¹ßÇ¥] TRIM11 protects against tauopathies and is down-regulated in A...